These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7539979)

  • 21. Detection of human topoisomerase II alpha in cell lines and tissues: characterization of five novel monoclonal antibodies.
    Kellner U; Heidebrecht HJ; Rudolph P; Biersack H; Buck F; Dakowski T; Wacker HH; Domanowski M; Seidel A; Westergaard O; Parwaresch R
    J Histochem Cytochem; 1997 Feb; 45(2):251-63. PubMed ID: 9016314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of monoclonal antibodies to a recombinant human topoisomerase II polypeptide.
    Robinson RG; Rapp L; Bowdish KJ; Graham MA; Huff AC; Coughlin SA
    Hybridoma; 1993 Aug; 12(4):407-15. PubMed ID: 8244417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
    Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
    Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonality characterization of natural epitope-specific antibodies against the tumor-related antigen topoisomerase IIa by peptide chip and proteome analysis: a pilot study with colorectal carcinoma patient samples.
    Linnebacher M; Lorenz P; Koy C; Jahnke A; Born N; Steinbeck F; Wollbold J; Latzkow T; Thiesen HJ; Glocker MO
    Anal Bioanal Chem; 2012 Apr; 403(1):227-38. PubMed ID: 22349330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
    Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
    Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.
    Barthelmes HU; Niederberger E; Roth T; Schulte K; Tang WC; Boege F; Fiebig HH; Eisenbrand G; Marko D
    Br J Cancer; 2001 Nov; 85(10):1585-91. PubMed ID: 11720449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.
    Hopfner R; Mousli M; Jeltsch JM; Voulgaris A; Lutz Y; Marin C; Bellocq JP; Oudet P; Bronner C
    Cancer Res; 2000 Jan; 60(1):121-8. PubMed ID: 10646863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cytochrome b5 tail anchors and stabilizes subdomains of human DNA topoisomerase II alpha in the cytoplasm of retrovirally infected mammalian cells.
    Soltermann A; Ernst A; Leroy D; Stahel RA; Gasser SM
    Exp Cell Res; 1999 Jun; 249(2):308-19. PubMed ID: 10366430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.
    Linka RM; Porter AC; Volkov A; Mielke C; Boege F; Christensen MO
    Nucleic Acids Res; 2007; 35(11):3810-22. PubMed ID: 17526531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications.
    Yu CC; Filipe MI
    Histochem J; 1993 Dec; 25(12):843-53. PubMed ID: 7906685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies.
    Roos G; Landberg G; Huff JP; Houghten R; Takasaki Y; Tan EM
    Lab Invest; 1993 Feb; 68(2):204-10. PubMed ID: 7680082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes.
    Kondapi AK; Satyanarayana N; Saikrishna AD
    Arch Biochem Biophys; 2006 Jun; 450(2):123-32. PubMed ID: 16712776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical study of DNA topoisomerase II in human gastric disorders.
    Yabuki N; Sasano H; Kato K; Ohara S; Toyota T; Nagura H; Miyaike M; Nozaki N; Kikuchi A
    Am J Pathol; 1996 Sep; 149(3):997-1007. PubMed ID: 8780403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of the cell cycle-associated monoclonal antibody Ki-S1 as a prognostic factor in primary invasive adenocarcinoma of the breast.
    Morris ES; Elston CW; Bell JA; Galea M; Blamey RW; Ellis IO
    J Pathol; 1995 May; 176(1):55-62. PubMed ID: 7616357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial characterization of the MPM-2 phosphoepitope.
    Ding M; Feng Y; Vandré DD
    Exp Cell Res; 1997 Feb; 231(1):3-13. PubMed ID: 9056407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The distribution of immunoreactive topoisomerase II Protein in human tissues and neoplasms.
    Holden JA; Rolfson DH; Wittwer CT
    Oncol Res; 1992; 4(4-5):157-66. PubMed ID: 1324031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis.
    Grigolo B; Mazzetti I; Borzì RM; Hickson ID; Fabbri M; Fasano L; Meliconi R; Facchini A
    Clin Exp Immunol; 1998 Dec; 114(3):339-46. PubMed ID: 9844041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.
    Dixon EP; King LM; Nelson R; Simkins SG; Knapp SL; Brough GH; Lenz KL; Henderson DT; Whitehead CM; Hessling J; Brown CA; Malinowski DP
    J Immunol Methods; 2017 Mar; 442():35-41. PubMed ID: 28093271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung.
    Giaccone G; van Ark-Otte J; Scagliotti G; Capranico G; van der Valk P; Rubio G; Dalesio O; Lopez R; Zunino F; Walboomers J
    Biochim Biophys Acta; 1995 Dec; 1264(3):337-46. PubMed ID: 8547322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.